Institution
Shandong Tumor Hospital
Also known as: Shandong Cancer Hospital · 山东省肿瘤医院
- 158running trials
- 40closed trials
- 9,984publications (OpenAlex)
Running trials
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Not yet recruiting
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma
Recruiting
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Recruiting
Recruiting
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Recruiting
Active, not recruiting
Recruiting
Showing 50 of 158.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer35 recruiting
- Metastatic breast cancer9 recruiting
- Colorectal cancer6 recruiting
- Gastric and oesophageal cancer5 recruiting
- Liver and biliary tract cancer5 recruiting
- Ovarian cancer5 recruiting
- Endometrial cancer4 recruiting
- Mantle cell lymphoma4 recruiting
- Pancreatic cancer4 recruiting
- Prostate cancer4 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Diffuse large B-cell lymphoma3 recruiting
- Neuroendocrine tumours3 recruiting
- Triple-negative breast cancer3 recruiting
- Bladder cancer2 recruiting
- Follicular lymphoma2 recruiting
- Head and neck cancer2 recruiting
- Multiple myeloma2 recruiting
- Cervical cancer1 recruiting
- Melanoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Recruiting
Terminated
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
Completed
Terminated
Terminated
Completed
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Completed
Completed
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Terminated
Terminated
Terminated
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Completed
Completed
Keynatinib in Treated Patients With NSCLC and Brain Metastases
Completed
Completed
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Registry name variants (28)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Shandong Cancer Hospital
Jinan, Shandong 250117
162 trials
Shandong University - Shandong Cancer Hospital
Jinan, Shandong 250117
5 trials
Shandong Cancer Hospital
Ji'nan, Shandong 250117
3 trials
Contact: Jinming Yu, Dr.
Contact: Yuping Sun
Contact: Jinming Yu
Shandong Cancer Hospital
Shandong
3 trials
Shandong Tumor Hospital
Jinan, Shandong 250117
2 trials
Contact: Coordinator Clinical operation director
NCT05740566Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Shandong Cancer Hospital /ID# 231577
Jinan, Shandong 251601
1 trial
Shandong Cancer Hospital /ID# 233200
Jinan, Shandong 251601
1 trial
Shandong Cancer Hospital /ID# 251506
Jinan, Shandong 251601
1 trial
Shandong Cancer Hospital /ID# 260808
Jinan, Shandong 251601
1 trial
Shandong Cancer Hospital /ID# 264036
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital, Shandong Cancer Institute
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 0041)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 0803)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 1321)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 1421)
Jinan, Shandong 250117
1 trial
Contact: Study Coordinator
Shandong Cancer Hospital (Site 1901)
Jinan, Shandong 250117
1 trial
Contact: Study Coordinator
Shandong Cancer Hospital (Site 2003)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 2200)
Jinan, Shandong 250117
1 trial
Contact: Study Coordinator
Shandong Cancer Hospital (Site 2205)
Jinan, Shandong 250117
1 trial
Contact: Study Coordinator
Shandong Cancer Hospital (Site 3108)
Jinan, Shandong 250117
1 trial
Contact: Study Coordinator
Shandong Cancer Hospital (Site 3112)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 3116)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 3119)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 5014)
Jinan, Shandong 250117
1 trial
Shandong Cancer Hospital (Site 8060)
Jinan, Shandong 250117
1 trial
Shandong Tumor Hospital
Shandong, Jinan
1 trial
Contact: Shandong Tumor Hospital Shandong Tumor Hospital
The first ward of breast Surgery, Shandong Cancer Hospital
Jinan, Shandong
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer300 works · 74 trials
- Liver and biliary tract cancer93 works · 13 trials
- Gastric and oesophageal cancer62 works · 19 trials
- Brain metastases38 works · 2 trials
- Ovarian cancer31 works · 9 trials
- Triple-negative breast cancer30 works · 9 trials
- Pancreatic cancer26 works · 6 trials
- Cervical cancer22 works · 4 trials
- Metastatic breast cancer19 works · 21 trials
Institution data: ROR 01413r497 (CC0-1.0)Updated 14 Nov 2026